- Home
- WAVE vs PPBT Comparison
WAVE vs PPBT Comparison
Compare WAVE & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAVE | PPBT |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5M | 2.4M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WAVE | PPBT |
|---|---|---|
| Price | $5.50 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | 12.7K | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $436.84 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.52 | $0.41 |
| 52 Week High | $10.87 | $5.18 |
Technical Indicators
Market Signals| Indicator | WAVE | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 29.40 | 53.12 |
| Support Level | $4.54 | $1.35 |
| Resistance Level | $6.49 | $1.85 |
| Average True Range (ATR) | 0.50 | 0.22 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 3.45 | 24.11 |
Price Performance
Historical ComparisonAbout WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.